What conditions does InxMed (Shanghai) Co., Ltd. run trials for?

In our tracked recruiting trials, InxMed (Shanghai) Co., Ltd. sponsors trials for Lung cancer, Non-Small Cell Lung Cancer, Pancreatic Cancer.

Clinical trials sponsored by InxMed (Shanghai) Co., Ltd.

Recruiting trials

Conditions studied

Phase 1 2Phase 2 2Phase 3 1

Condition	Trials
Lung cancer	2
Non-Small Cell Lung Cancer	1
Pancreatic Cancer	1
Small Cell Lung Cancer Extensive Stage	1

A Phase 3 Study of IN10018 in Combination With D-1553 Versus Standard Therapy for First Line Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation
NCT07174908 · Phase: Phase 3 · Ages: 18 Years to 80 Years · Sex: All (male and female) · 11 locations
IN10018 Combination Therapy in Treatment-naïve ES-SCLC
NCT06030258 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 3 locations
IN10018+ Standard Chemotherapy (+KN046) in Subjects With Advanced Pancreatic Cancer
NCT05827796 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location

InxMed (Shanghai) Co., Ltd. is the lead sponsor of 3 recruiting trials.

No. For the full record, search ClinicalTrials.gov.